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A B S T R A C T
Background: endothelial cells play a key role in vessels formation both under physiological and pathological
conditions. Their behavior is influenced by blood components including gasotransmitters (H2S, NO and CO).
Tumor cells are subjected to a cyclic shift between pro-oxidative and hypoxic state and, in this scenario, H2S can
be both cytoprotective and detrimental depending on its concentration. H2S effects on tumors onset and
development is scarcely studied, particularly concerning tumor angiogenesis. We previously demonstrated that
H2S is proangiogenic for tumoral but not for normal endothelium and this may represent a target for
antiangiogenic therapeutical strategies.
Methods: in this work, we investigate cell viability, migration and tubulogenesis on human EC derived from two
different tumors, breast and renal carcinoma (BTEC and RTEC), compared to normal microvascular
endothelium (HMEC) under oxidative stress, hypoxia and treatment with exogenous H2S.
Results: all EC types are similarly sensitive to oxidative stress induced by hydrogen peroxide; chemical hypoxia
differentially affects endothelial viability, that results unaltered by real hypoxia. H2S neither affects cell viability
nor prevents hypoxia and H2O2-induced damage. Endothelial migration is enhanced by hypoxia, while
tubulogenesis is inhibited for all EC types. H2S acts differentially on EC migration and tubulogenesis.
Conclusions: these data provide evidence for a great variability of normal and altered endothelium in response
to the environmental conditions.
1. Introduction
During physiological tissue development, vasculature organization
and sprouting varies to meet blood demand. In solid tumors, however,
the abnormal cell proliferation and vascular disorganization cause an
insufficient blood supply, leading to glucose deprivation and hypoxia
[1]. The hypoxic environment of tumors is heterogeneous, both
spatially and temporally, and can change in response to cytotoxic
therapy. Carcinomas usually support their growth by stimulating blood
vessel development (angiogenesis) [2,3]. Blood flow within these new
vessels is often chaotic, causing alternating periods of hypoxia followed
by re-oxygenation. Reperfusion is well established to cause generation
of reactive oxygen species (ROS) exacerbating the ischemic injury
especially after myocardial or cerebral ischemia [4,5]. Oxygen radicals
production during reperfusion may, therefore, represent a source of
ROS also within breast carcinomas and other solid tumors. In addition,
in breast tumor, glucose deprivation rapidly induces cellular oxidative
stress, as demonstrated in MCF-7 breast carcinoma cell line, although
it does not cause oxidative stress in non-transformed cell lines [6]. This
may be due to glucose deprivation, which depletes intracellular
pyruvate within the breast carcinoma cell, preventing the decomposi-
tion of endogenous oxygen radicals.
In recent years increasing evidences emerged on the role of the
bioactive gaseous molecule H2S in normal and tumor vascularization
[7,8]. In vascular endothelium H2S may act as vasorelaxant and anti-
inflammatory agent as well as a powerful stimulator of angiogenesis.
Indeed, H2S promotes mitosis, migration and tubulogenesis in human
umbilical vein EC (HUVEC) and in the retinal endothelial cell (EC) line
RF/6A [9,10].
Oxidative stress promotes cell death in response to a variety of
pathophysiological conditions and an excessive amount of ROS,
including hydrogen peroxide (H2O2), leads to lethal vascular endothe-
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lial cell injury [11]. Hydrogen sulfide has been shown to be protective
against H2O2-induced oxidative stress: for example, 25–100 µM NaHS
enhances cell survival upon H2O2 treatment in H9c2 cardiomyoblasts
[12].
We recently described the effects of H2S on microvascular EC
obtained from human breast carcinoma (BTEC). Ca2+ imaging and
patch-clamp experiments revealed that acute perfusion with NaHS (a
saline H2S donor) induces [Cai] increases, as well as [K
+
i] and non-
selective cationic currents [13]. Stimulation with NaHS, at the same
concentration range (1 nM–200 μM), evoked Cai signals also in normal
human microvascular EC (HMVEC), although the amplitude was
significantly lower. Conversely, doses lower than 10 μM of NaHS did
not evoke any detectable elevation in Cai in the excised endothelium of
rat aorta. Moreover, NaHS failed to promote either migration or
proliferation on HMVEC, while BTEC migration was enhanced at
low-micromolar NaHS concentrations (1–10 μM) [13]. Remarkably,
pretreatment with an inhibitor of endogenous H2S production (PAG),
drastically reduced migration and Cai signals induced by Vascular
Endothelial Growth Factor (VEGF) in BTEC. These data suggest that
H2S plays a role in proangiogenic signaling of tumor-derived but not
normal human EC pointing to a potential differential sensitivity of
normal EC compared to TEC that could be an interesting tool for tumor
angiogenesis treatment. Furthermore, its ability to interfere with BTEC
responsiveness to VEGF suggests that it could be an interesting target
for antiangiogenic strategies in tumor treatment.
Here we unveil a great variability in the functional responses to
hypoxia and oxidative stress and their regulation by exogenous H2S in
endothelial cells derived from two different human carcinomas as well
as normal microvascular endothelium.
2. Materials and methods
2.1. Cell cultures
Breast tumor-derived endothelial cells (BTEC) and renal tumor-
derived endothelial cells (RTEC) from human breast lobular-infiltrat-
ing carcinoma biopsy and renal carcinoma respectively, were isolated
and periodically characterized in the laboratory of Professor Benedetta
Bussolati (Department of Internal Medicine, Molecular Biotechnology
Center and Research in Experimental Medicine Center, University of
Torino, Italy). BTEC and RTEC were grown in EndoGRO-MV-VEGF
Complete Media Kit, composed of EndoGRO Basal Medium and
EndoGRO-MV-VEGF Supplement Kit (Merck Millipore). EndoGRO
Basal Medium is a low-serum culture media for human microvascular
endothelial cells, supplemented with a kit containing rhVEGF (5 ng/
ml), rhEGF (5 ng/ml), rhFGF (5 ng/ml), rhIGF-1 (15 ng/ml), L-gluta-
mine (10 mM), hydrocortisone hemisuccinate (1.0 μg/ml), heparin
sulfate (0.75 U/ml), ascorbic acid (50 μg/ml), fetal bovine serum FCS
5%. Human microvascular endothelial cells (HMEC) are dermal-
derived cells purchased from Lonza. HMEC, as well as BTEC, were
grown in EndoGRO-MV-VEGF Complete Media Kit.
All cell cultures were maintained in normoxic (37 °C, 21% O2 and
5% CO2) and, when needed, hypoxic (37 °C, 5% O2 and 5% CO2)
incubator (InVIVO2 200 equipped with a Ruskinn Gas Mixer Q) using
Fig. 1. High H2O2 and chemical hypoxia are toxic for EC. A) Representative dose-response curve of cytotoxicity assay on HMEC, BTEC and RTEC upon treatment with H2O2 (50–
800 µM; 24 h). Data are expressed as the mean ± S.E.MWilcoxon test: *p < 0.0001 vs CNTRL. B) Cytotoxicity experiment (24 h) performed on EC under normoxic or hypoxic conditions
(see Section 2), in DMEM 1% FCS medium. Data from a representative experiment are expressed as the mean ± S.E.M. Wilcoxon test. C) Viability assay on EC treated with CoCl2
(100 µM; 24 h). Data from a representative experiment are expressed as the mean ± S.E.M. Wilcoxon test: **p < 0.001 vs CNTRL. CNTRL: DMEM 1% FCS medium.
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Falcon™ plates as supports (about 5000 cells/cm2) and were used at
passages 3–15. BTEC were cultured on 1% gelatin coating.
Chemical hypoxia was achieved by adding 100 µM CoCl2 to the
medium for the indicated times (see Section 3).
All experiments were performed using DMEM, Dulbecco's modified
eagle medium (Sigma-Aldrich Corporate, MO, USA), with 4500 mg/L
glucose, 15 mM HEPES and sodium bicarbonate. DMEM was supple-
mented with 2% L-glutamine, 0.5% gentamicin, and 1% fetal calf serum
(FCS).
2.2. Chemicals
H2S donor NaHS was prepared fresh in stock solutions of 5 mM by
dissolving the salt in deionized water. All experimental final concen-
trations were obtained by dilution in the culturing medium. Due to the
well-known H2S volatility, dilution was made just before each experi-
ment. NaHS releases H2S in a ratio of approximately 3:1.
CoCl2 and Hydrogen peroxide were purchased from Sigma-Aldrich
(St Louis, MO, USA).
2.3. Viability and proliferation assays
Cells were plated on 96-well culture plates (104 or 0.5 ∙ 104 cells/
well for viability and proliferation assays, respectively, on the basis of
their duplication time (~30 h) in DMEM 1% FCS with/without treat-
ments (4 wells/condition), considering. After 24 h (viability assay) or
72 h (proliferation assay) of treatment, cells were colored using the
CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay
(Promega, Madison, WI, USA), using 3-(4,5-dimethylthiazol-2-yl)-5-
(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H tetrazolium, inner
salt (MTS). MTS conversion into the aqueous soluble formazan product
Fig. 2. H2S is not protective for EC against oxidative stress and chemical hypoxia
toxicity. Cytotoxicity assay of HMEC, BTEC and RTEC treated for 24 h with NaHS (1–
10–100 µM) and H2O2 (200 or 400 µM) (A) or CoCl2 100 µM (B) or the combination of
the two, evaluated with MTS colorimetric kit (see Section 2). C) Proliferation assay of
HMEC, BTEC and RTEC maintained for 72 h with NaHS (1–10–100 µM), evaluated with
MTS colorimetric kit. Data from a representative experiment were normalized to the
respective CNTRL and are expressed as the mean ± S.E.M. Wilcoxon test: *p < 0.01, **p
< 0.0001 vs CNTRL, #p < 0.001 vs CoCl2 100 µM;
$p < 0.0001. CNTRL: DMEM 1% FCS
medium.
Fig. 3. Effects of hypoxia and CoCl2 on EC migration and tubulogenesis. A)
Representative wound healing experiment in normoxic and hypoxic condition (see
Section 2) on HMEC, BTEC and RTEC. Percentage of migration at 12 h in DMEM 1%
FCS medium. Data are expressed as mean ± S.E.M: *p < 0.0001 vs. normoxia. Percentage
of migration at 12 h (B) and tubulogenic potential (C) of HMEC, BTEC and RTEC upon
chemical hypoxic condition (CoCl2 100 µM) treatment. Data were normalized to
respective control and are expressed as mean ± S.E.M: *p < 0.01, **p < 0.0001 vs
CNTRL. CNTRL: DMEM 1% FCS medium.
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is accomplished by dehydrogenase enzymes found in metabolically
active cells. Formazan product was measured as absorbance in a Bio-
Rad microplate reader Model 550 (Bio-Rad, Hercules, CA, USA) at
490 nm; the values reported are directly proportional to the viable cell
number at 24 and 72 h.
2.4. Cell migration assay
Scratch Wound Healing Assay. Cells were plated (2.5 ∙ 104 cells/
cm2) using EndoGRO 5% FCS on 24-well culture plates pre-coated with
1% gelatin. Cells were maintained in incubator until confluence was
reached. All cell types monolayers were starved for 6 h in DMEM 0%
FCS. Motility assay was performed by generating a wound in the
confluent cellular monolayers with a P10-pipette tip. Floating cells
were removed by wash in PBS solution, and monolayers underwent to
different experimental conditions (in duplicate). Incubation with
DMEM 1% FCS served as control.
Experiments were performed under a Nikon Eclipse Ti (Nikon
Corporation, Tokio, Japan) inverted microscope equipped with a A.S.I.
MS-2000 stage and a OkoLab incubator (to keep cells at 37 °C and 5%
CO2). Images were acquired at 2 h intervals using a Nikon Plan 4×/
0.10 objective and a CCD camera. MetaMorph software (Molecular
Devices, Sunnyvale, CA, USA) was used to acquire images for 5
consecutive time points.
2.5. In vitro angiogenesis assay
In vitro formation of ‘capillary-like’ structures was studied on
growth factor-reduced Matrigel (BD Bioscience, NJ, USA). Cells were
seeded (3.5 ∙ 104 cells/well) onto Matrigel-coated 24-well plates in
growth medium containing treatments (in duplicate). DMEM 1% FCS
was used as control. Cell organization into Matrigel was periodically
observed with the same set-up described above for wound healing
assay and one-side migration assays using a Nikon Plan 10×/0.10
objective. Images were acquired at 2 h time intervals (9 time points)
using MetaMorph software.
2.6. Radical oxygen species (ROS) detection assay
Cells were plated as described above for cytotoxicity assay. After
Fig. 4. Differential effects of H2S on EC migration and tubulogenesis. A-B)
Representative Cell migration experiment on EC stimulated with NaSH (1–10–
100 µM) and/or CoCl2 in hypoxia (A) or normoxia (B) conditions. Data were normalized
to the respective CNTRL and are expressed as the mean ± S.E.M. Wilcoxon test: *p <
0.01, **p < 0.0001 vs CNTRL normoxia; $p < 0.05, $$p < 0.001, $$$p < 0.0001 vs CNTRL
hypoxia; §p < 0.01, §§p < 0.0001 vs normossia; #p < 0.001, ##p < 0.0001 vs CoCl2 100 µM.
C) In vitro tubulogenesis assay upon CoCl2 100 µM and NaHS treatment and the
combination of the two of HMEC, BTEC and RTEC at 18 h. Tubulogenic potential
express the total vessels length normalized to respective control. Total vessel length was
measured for each field. Data are expressed as mean ± S.E.M Wilcoxon test: **p < 0.001
vs CNTRL; #p < 0.01, ##p < 0.0001 vs NaHS 1 µM; $p < 0.01 vs NaHS 10 µM; §p < 0.01,
§§p < 0.001 vs NaHS 100 µM. CNTRL: DMEM 1% FCS medium.
Fig. 5. Endothelial ROS concentration. Endothelial ROS level evaluation in normoxic,
hypoxic and re-oxygenation (see Section 2) conditions (A) or upon NaHS stimulation (1–
10–100 µM) in normoxia (B). Data were normalized to the respective CNTRL and are
expressed as the mean ± S.E.M. Wilcoxon test: *p < 0.01, **p < 0.0001 vs CNTRL.
CNTRL: DMEM 1% FCS.
S. Bianco et al. Redox Biology 12 (2017) 499–504
502
24 h of treatment, 2′,7′-Dichlorofluorescin diacetate (Sigma Aldrich)
was added (10 µM) to cell culturing medium for 30 min. For hypoxia-
reperfusion protocol, cells were maintained in hypoxia for 24 h and
then in normoxia for 30 min. Fluorescence intensity, directly propor-
tional to intracellular ROS concentration, was detected with a Bio-Rad
microplate reader Model 550 (Bio-Rad, Hercules, CA, USA) at 530 nm.
2.7. Data analysis and statistics
In viability assays, absorbance values were analyzed with Excel
software (Office, Microsoft) and normalized to the control.
Wound healing experiments were analyzed using Metamorph soft-
ware. Cell migration was assessed by measuring the distance between
the two sides of the wound at each time point. Data were further
analyzed using Excel in order to calculate the percentage of migration
for each wound (differential distance between cell fronts at two
subsequent time points over distance at time 0) and the percentage
mean value for each condition was then calculated. At least six fields for
each condition were analyzed for every independent experiment.
Where indicated, data were normalized to the control (100%) and
relative migration was calculated, evaluating the propagation of errors
for the S.E.M. of each treatment.
In in vitro angiogenesis assay, tubule length was evaluated with
ImageJ and normalized to the control. Total tubule length for each
condition was used to express the degree of organization in ‘capillary-
like’ structures in terms of arbitrary units (AU). At least ten fields for
each condition were analyzed in each independent experiment.
Statistical analysis of data was performed using the non-parametric
Wilcoxon-Mann-Whitney test with Kaleidagraph software (Synergy
Software). Data considered significant showed a p-value (p) < 0.05.
All experiments were carried out with a minimum of two biological
replicates for each experimental condition. All experiments were
repeated at least three independent times.
3. Results and discussion
3.1. Effect of H2O2 and hypoxia on endothelial cell viability
We first evaluated the viability of normal and tumor-derived human
microvascular endothelial cell exposed to H2O2-induced oxidative
stress and either chemically-induced or real hypoxia.
Incubation with H2O2 (from 50 to 800 µM) decreased cell viability
upon 24 h of treatment both in normal (HMEC) and tumor-derived
endothelium (breast and renal carcinoma-derived, BTEC and RTEC
respectively), starting from 200 µM of H2O2 (Fig 1A): this observation
is in line with the literature [11,14]. On the other hand, hypoxia (37 °C,
5% O2 and 5% CO2; 8 h) did not affect the viability of all the three EC
types measured at 24 h (Fig. 1B). Chemical hypoxia induced by high
CoCl2 concentration (100 µM) differentially affected EC viability.
Indeed, HMEC and BTEC survival was drastically reduced by CoCl2,
leaving RTEC unaffected (Fig. 1C). This result suggests that EC from
different tumors display a variable sensitivity to such a particular stress
[15–18].
3.2. H2S is not protective against H2O2 and CoCl2-induced
cytotoxicity and differentially affects EC proliferation
We previously demonstrated that exogenous H2S (released by a
saline donor, NaHS) exerts proangiogenic effects in BTEC but not in
HMEC. We therefore investigated whether the gasotransmitter could
prevent the cytotoxicity provoked by H2O2 and CoCl2. NaHS alone was
ineffective on EC viability at all the tested concentrations, although a
slight (although not significant) effect was observed on HMEC. It failed
to prevent cytotoxicity induced by high H2O2 (200 and 400 µM) in both
normal HMEC and tumor-derived BTEC (Fig. 2A).
When administered in the presence of CoCl2, NaHS did not rescue
the toxic effects of chemical hypoxia, whereas the combination of the
two treatments further reduced RTEC survival (Fig. 2B).
Moreover, high H2S concentrations (10–100 µM) inhibit HMEC,
but not TEC, proliferation (Fig. 2C).
3.3. Hypoxia promotes endothelial migration but inhibits
tubulogenesis
There is considerable evidence that hypoxia upregulates VEGF and
angiopoietin 2, leading to the initiation and promulgation of angiogen-
esis [19,20]. For this reason, we decided to evaluate the outcomes of
hypoxia and exogenous H2S on EC migration and tubulogenesis.
Here we show that hypoxia (8 h, 5% O2) enhances migration in all
EC types grown in DMEM with 1% FCS (Fig. 3A). The same behavior
was observed in the three EC types treated with CoCl2, with a migratory
activity greater than in normoxic condition. Interestingly, the effect was
particularly enhanced in BTEC (Fig. 3B).
Exposure to CoCl2 significantly decreased tubulogenic potential of
all cell types tested (Fig. 3C), unlike previously reported for HUAEC
and HUVEC [21,22].
3.4. H2S differentially affects endothelial migration and is unable to
revert the antitubulogenic effect of CoCl2
H2S displays variable effects on EC migration (Fig. 4A). Indeed,
HMEC as well as RTEC migration were unaffected by all NaHS
concentrations, while BTEC migration was strongly enhanced by the
same NaHS treatments (Fig. 4A-B). Hypoxic conditions, as mentioned
above, enhance migration in all EC when compared to normoxia. When
H2S was administered during hypoxia, it partially rescued the hypoxia-
induced effect in all three EC types, with a greater efficacy in RTEC.
We therefore tested the effect of NaHS on the CoCl2-dependent
migration. In HMEC, co-treatment with CoCl2 and NaHS showed that
the CoCl2 promigratory effect was reverted by the lowest concentration
of NaHS. In RTEC, in which NaHS alone was not effective, co-
incubation of NaHS and CoCl2 prevented the pro-migratory activity
of CoCl2 alone.
Interestingly, the combined treatment with CoCl2 and 1 µM NaHS
limited BTEC migration, when compared to the two separate treat-
ments (Fig. 4A). As previously shown in viability assays, TEC and
HMEC display differential responsiveness to H2S and/or CoCl2 ex-
posure.
H2S promoted differential effects on CoCl2-induced EC tubulogen-
esis. The lowest concentration of NaHS tested (1 µM) enhanced
tubulogenesis only in BTEC, while the higher concentration (100 µM)
was anti-tubulogenic for HMEC. RTEC tubulogenic potential was not
affected by all concentrations of NaHS (Fig. 4B). The combination of
CoCl2 and NaHS did not rescue the inhibition of tubulogenesis induced
by CoCl2 alone in all cell types.
Taken together, our data reveal an overall great variability of
different EC types, either normal and tumor-derived, in the response
to chemically-induced or real hypoxia, as well as to H2S treatment. In
addition, H2S activity strongly depends on its concentration, as already
reported by previous reports on endothelial and other cell types
[23,24].
Moreover, evidence provided in this work indicates that H2S is not
protective against hypoxia and oxidative stress for normal and altered
vascular endothelium, differently from its well-known role on the heart
[25,26].
3.5. High doses of H2S affect ROS production only in RTEC
The tumor vasculature, due to its continuous mutation, causes
alternation of hypoxia and re-oxygenation periods, which is well known
to bring to a reactive oxygen species (ROS) production in diverse
situation as in myocardial ischemia [4]. This condition leads to an
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oxidative stress state that alters cell metabolism and behavior.
Under hypoxic conditions, ROS level in all the EC types was lower
than in normoxia, while during reperfusion is strongly increased
(Fig. 5A). In normoxic environment, NaHS administration differen-
tially affected ROS production. Indeed, only RTEC were affected by
high doses of H2S with significant ROS reduction, while BTEC and
HMEC were insensitive (Fig. 5B).
These data confirm the diverse sensitivity of EC to H2S, but also
suggest that ROS unlikely play a relevant role in the differential
functional behaviors previously observed.
4. Conclusions
Oxidative stress and hypoxia have been shown to play a role in cell
death and angiogenesis [11,20]: moreover, H2S exerts a protective role
against ROS in rat cardiomyoblasts [12], is promigratory and proan-
giogenic for HUVEC and retinal EC, but not for HMEC [9,13,25].
Here we report that human endothelial cells derived from two
different tumors and from normal microvasculature are differentially
sensitive to hypoxia and oxidative stress, as well as to their regulation
by H2S. This variability should be carefully considered for a correct
interpretation of the vascular effects observed upon antiangiogenic
treatments in normal and altered tissues.
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